METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Clinical trials for METASTATIC CASTRATION RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for men with advanced prostate cancer: radioactive drug trial seeks to control disease after other treatments fail
Disease control Not yet recruitingThis trial is testing a new radioactive drug called Actinium rhPSMA-10.1 for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. The drug is designed to find and destroy prostate cancer cells throughout the body using targeted …
Matched conditions: METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New pill targets Tough-to-Treat prostate cancer in early trial
Disease control Not yet recruitingThis early-stage study is testing a new oral medication called TQB3201 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone-blocking treatments. The main goals are to find a safe dose, see how the body processes the drug, and get a…
Matched conditions: METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
First-in-Human trial tests new hope for tough cancers
Disease control Not yet recruitingThis is the first study in people to test a new drug called ITC-6146RO for patients with advanced or metastatic cancer who have run out of standard treatment options. The main goals are to find a safe dose and see how the body processes the drug. The study will enroll about 102 a…
Matched conditions: METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New drug trial aims to outperform chemo for tough prostate cancer
Disease control Not yet recruitingThis study is testing if an experimental drug called BNT324 helps men with advanced prostate cancer live longer or live longer without their cancer getting worse, compared to the current standard chemotherapy. It will involve about 736 men whose cancer has spread and stopped resp…
Matched conditions: METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC